Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$26.74 -0.59 (-2.16%)
As of: Sep 29, 2026 · 3:59 PM EDT

Arcutis Biotherapeutics (ARQT) Total Current Liabilities (2019 - 2026)

Updated

Arcutis Biotherapeutics' Total Current Liabilities was $160.34 million in Q2 2026, up 54.3% from $103.94 million a year earlier but down 1.8% from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Total Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Arcutis Biotherapeutics came in at $129.84 million, up 60.3% from FY2024.

  • Total Current Liabilities has now increased for six consecutive years, with a five-year compound annual growth rate of 41.9% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $81.01 million in FY2024 (+73.6%), $46.67 million in FY2023 (+23.4%), $37.81 million in FY2022 (+13.4%) and $33.33 million in FY2021 (+47.4%).
  • Quarterly Total Current Liabilities has moved between $19.06 million (Q3 2021) and $172.43 million (Q3 2024) over five years.
  • Compared with a year earlier, Total Current Liabilities has increased for three straight quarters, with growth averaging 91.5% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q3 2024 (growth of 311.6%); the worst was Q3 2025 (a decline of 42.1%).
  • Per Business Quant data, ARQT's Total Current Liabilities in the three quarters before Q2 2026 was $163.2 million (Q1 2026), $129.84 million (Q4 2025) and $99.77 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Arcutis Biotherapeutics 3.43 Bn 2.72 Bn 118.92 Mn 160.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 160.34 Mn
Mar 31, 2026 163.20 Mn
Dec 31, 2025 129.84 Mn
Sep 30, 2025 99.77 Mn
Jun 30, 2025 103.94 Mn
Mar 31, 2025 91.13 Mn
Dec 31, 2024 81.01 Mn
Sep 30, 2024 172.43 Mn
Jun 30, 2024 51.35 Mn
Mar 31, 2024 47.31 Mn
Dec 31, 2023 46.67 Mn
Sep 30, 2023 41.89 Mn
Jun 30, 2023 36.66 Mn
Mar 31, 2023 37.03 Mn
Dec 31, 2022 37.81 Mn
Sep 30, 2022 37.10 Mn
Jun 30, 2022 27.48 Mn
Mar 31, 2022 32.96 Mn
Dec 31, 2021 33.33 Mn
Sep 30, 2021 19.06 Mn
API Access

Arcutis Biotherapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ARQT&period=max&api_key=YOUR_API_KEY